Nymox Pharmaceutical
NYMX
#9275
Rank
S$23.77 M
Marketcap
Bahamas
Country
$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -$0.08223

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.07815. In 2022 the company made an earnings per share (EPS) of -$0.10 an increase over its 2021 EPS that were of -$0.20.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.08223-21.08%
2022-$0.10-46.67%
2021-$0.20-11.76%
2020-$0.22-15%
2019-$0.265.26%
2018-$0.25-26.92%
2017-$0.34-7.14%
2016-$0.36-40.43%
2015-$0.61291.67%
2014-$0.16-7.69%
2013-$0.17-43.48%
2012-$0.30-25.81%
2011-$0.4055%
2010-$0.2625%
2009-$0.210.08%
2008-$0.21-11.12%
2007-$0.23-0.16%
2006-$0.2328.59%
2005-$0.18-12.49%
2004-$0.21-16.05%
2003-$0.2519.07%
2002-$0.2114.45%
2001-$0.18-22.16%
2000-$0.235.64%
1999-$0.22-34.59%
1998-$0.34-3.6%
1997-$0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.87-5,053.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42-3,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.81-11,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.07-9,148.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.35-23,575.50%๐Ÿ‡บ๐Ÿ‡ธ USA